• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

Introduction to (3R,4R)-3-fluoro-1-methyl-piperidin-4-amine; dihydrochloride (CAS No. 2306246-14-8)

(3R,4R)-3-fluoro-1-methyl-piperidin-4-amine; dihydrochloride, with the CAS number 2306246-14-8, is a significant compound in the field of pharmaceutical chemistry. This compound belongs to the piperidine class of heterocyclic amines, which has garnered considerable attention due to its versatile applications in drug development. The presence of a fluoro substituent and specific stereochemistry at the 3R and 4R positions enhances its pharmacological properties, making it a valuable intermediate in the synthesis of various therapeutic agents.

The dihydrochloride salt form of this compound improves its solubility and stability, which are critical factors in pharmaceutical formulations. These attributes make it particularly useful in medicinal chemistry for the development of novel drugs targeting neurological and cardiovascular diseases. Recent advancements in drug design have highlighted the importance of fluorinated piperidine derivatives due to their ability to modulate enzyme activity and receptor binding affinity.

In recent years, researchers have been exploring the potential of (3R,4R)-3-fluoro-1-methyl-piperidin-4-amine; dihydrochloride in the treatment of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Studies have demonstrated that fluorinated piperidines can enhance the efficacy of drugs by improving metabolic stability and reducing systemic toxicity. The stereochemical configuration at the 3R and 4R positions plays a crucial role in determining the biological activity of this compound, making it a focal point for further investigation.

Moreover, the pharmaceutical industry has shown interest in this compound for its potential application in antipsychotic and antidepressant therapies. The fluoro group contributes to the compound's ability to interact with central nervous system receptors, thereby influencing neurotransmitter activity. This interaction is pivotal in developing treatments for mental health disorders where modulation of neurotransmitter pathways is essential.

Recent clinical trials have begun to explore the efficacy of derivatives of (3R,4R)-3-fluoro-1-methyl-piperidin-4-amine; dihydrochloride in managing chronic pain conditions. The compound's structural features allow it to interact with pain-signaling pathways, offering a potential alternative or adjunct therapy for patients suffering from neuropathic pain. These preliminary findings are encouraging and warrant further research into its mechanisms of action and therapeutic potential.

The synthesis of this compound involves multi-step organic reactions that require precise control over reaction conditions to achieve high yields and purity. Advanced synthetic methodologies, including asymmetric catalysis and flow chemistry, have been employed to optimize the production process. These techniques not only improve efficiency but also minimize environmental impact, aligning with current trends toward sustainable pharmaceutical manufacturing.

In conclusion, (3R,4R)-3-fluoro-1-methyl-piperidin-4-amine; dihydrochloride represents a promising candidate for further development in pharmaceuticals. Its unique structural features and demonstrated biological activity make it a valuable asset in drug discovery efforts. As research continues to uncover new therapeutic applications, this compound is poised to play a significant role in addressing various medical challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)